Entries by Irina Penzo

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

Bottom line and this study out today is telling us what we already knew from prior studies across the last over one year. The study shows that vaccination/injection/inoculation using both mRNA vaccines (Pfizer and Moderna) was related to an increased risk of myocarditis and pericarditis within the first 7 days post vaccination. The study showed […]

The impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound

Hay et al, Harvard, mandated products backfiring and making the PCR stay positive longer in compliant compared to sage unjected subjects. Employers should look carefully at ill-advised mandates and review these curves as compliant employees get sick and want to return to work. View PDF Directly: https://www.medrxiv.org/content/10.1101/2022.01.13.22269257v2.full.pdf Source: https://www.medrxiv.org/content/10.1101/2022.01.13.22269257v2

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series

Baumeier et al, Berlin, cardiac biopsies reveal giant cell and presence of Spike protein within myocardial tissue. Giant cells are predictive of cardiac death. Presence of Spike evidence of causality for mandated products producing heart damage. @HighWireTalk @fynn fan Source: https://www.mdpi.com/1422-0067/23/13/6940

SARS-CoV-2 spike protein expressing epithelial cells promotes senescence associated secretory phenotype in endothelial cells and increased inflammatory response

Meyer, St. Louis Univ, Spike causes cells to age more rapidly across an array of in vitro measures. Repeated doses every six months may accelerate the aging process; congruent with reports of increasing and more aggressive cancers and progression of ASCVD. RX ideas in Figure. View PDF Directly: https://www.biorxiv.org/content/10.1101/2021.04.16.440215v1.full.pdf Source: https://www.biorxiv.org/content/10.1101/2021.04.16.440215v1

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

Van Egeren et al, Harvard, PLOS, explains how mutations render the mandated products useless but still has enough RBD integrity to cause infection.   The worldwide failure of the program occurred with a narrow band of epitopes had no hope for durable protection.  Anticipated. View PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081162/pdf/pone.0250780.pdf Source: https://pubmed.ncbi.nlm.nih.gov/33909660/